Silo Pharma, Inc. (SILO) Institutional Ownership

Ownership Summary

The institutional landscape for Silo Pharma, Inc. (NASDAQ:SILO) includes 14 filers as of the latest reporting cycle ending December 2025.

• Institutional ownership in Silo Pharma edged down to 12.9% in December 2025, compared to 16.8% in September 2025.
• Institutional share ownership changed by 159.29% QoQ, while the number of institutional owners saw a decrease of 12.50% YoY.
• The latest 13F cycle for Silo Pharma reveals that of 14 total investors, 9 funds grew their exposure, whereas 2 reduced theirs and 3 made no changes.
• The total number of shares held by institutions in Silo Pharma increased to 1.20Mn as of December 2025, a net change of up by 734.27K shares quarter on quarter, and up 1.01Mn shares year over year.
• The top institutional stake in Silo Pharma as of December 31, 2025 belongs to AdvisorShares Investments LLC, which owns 599.51K shares, or 6.48% of the company.
• Among the most significant buyers of Silo Pharma during December 2025 were DRW Securities, LLC (333.73K), AdvisorShares Investments LLC (234.63K), XTX Topco Ltd (56.90K), GEODE CAPITAL MANAGEMENT, LLC (53.31K), SUSQUEHANNA INTERNATIONAL GROUP, LLP (29.58K).
• Leading sellers of Silo Pharma stock in December 2025 included UBS Group AG (2.94K), Tower Research Capital LLC (TRC) (12).
• The top 10 institutional holders of Silo Pharma for the quarter ending December 2025 included AdvisorShares Investments LLC (599.51K), DRW Securities, LLC (333.73K), GEODE CAPITAL MANAGEMENT, LLC (92.91K), XTX Topco Ltd (56.90K), JANE STREET GROUP, LLC (34.37K), SUSQUEHANNA INTERNATIONAL GROUP, LLP (29.58K), VANGUARD GROUP INC (24.32K), STATE STREET CORP (12.50K), UBS Group AG (6.04K), CITIGROUP INC (3.45K).